Sydnee Torrence Weber
Physician Assistant · Portland, ORNPI 1386124881
Payments from drug & device makers
Across 104 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$649
- Vanda Pharmaceuticals Inc.$341
- Teva Pharmaceuticals USA, Inc.$249
- Lundbeck LLC$154
- Pfizer$143
- AbbVie$122
- plus $637 from 14 others
What the payments were for
- Food & beverage$2,19696%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $649 |
| Vanda Pharmaceuticals Inc. | 14 | $341 |
| Teva Pharmaceuticals USA, Inc. | 9 | $249 |
| Lundbeck LLC | 7 | $154 |
| Pfizer | 9 | $143 |
| AbbVie | 6 | $122 |
| Alkermes, Inc. | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Neurocrine Biosciences, Inc. | 3 | $69 |
| Exact Sciences | 3 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $53 |
| Merck | 3 | $48 |
| Lilly USA, LLC | 3 | $44 |
| Bausch Health US, LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| AstraZeneca | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Medicomp Inc | 1 | $16 |
How this compares
$2,295 in reported general payments places this provider in the 90th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RayaldeeCalcifediol | 13 | $15,229 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $458 |
| Levothyroxine Sodium | 27 | $360 |
| Atorvastatin Calcium | 30 | $320 |
| Escitalopram Oxalate | 11 | $168 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $165 |
| Metformin Hcl | 13 | $146 |
| Losartan Potassium | 18 | $98 |
| Alprazolam | 13 | $50 |
| Lisinopril | 17 | $35 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Portland
- Sean BrownPortland$43K
- Meegan MangumPortland$25K
- Scott FrazeePortland$24K
- Lucy NusralaPortland$9K
- Thomas SextonPortland$9K
- Madelyn DoPortland$8K
- Kevin BrandtPortland$8K
- Virginia WhitneyPortland$8K
- Mary BurnellPortland$7K
- William SimpsonPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.